Exploring the transcriptomic landscape of moyamoya disease and systemic lupus erythematosus: insights into crosstalk genes and immune relationships
Authors:
Open Access
- 3 September 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1456392
Abstract
Background: Systemic Lupus Erythematosus (SLE) is acknowledged for its significant influence on systemic health. This study sought to explore potential crosstalk genes, pathways, and immune cells in the relationship between SLE and moyamoya disease (MMD).Methods: We obtained data on SLE and MMD from the Gene Expression Omnibus (GEO) database. Differential expression analysis and weighted gene co-expression network analysis (WGCNA) were conducted to identify common genes. Subsequently, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed on these shared genes. Hub genes were further selected through the least absolute shrinkage and selection operator (LASSO) regression, and a receiver operating characteristic (ROC) curve was generated based on the results of this selection. Finally, single-sample Gene Set Enrichment Analysis (ssGSEA) was utilized to assess the infiltration levels of 28 immune cells in the expression profile and their association with the identified hub genes.Results: By intersecting the important module genes from WGCNA with the DEGs, the study highlighted CAMP, CFD, MYO1F, CTSS, DEFA3, NLRP12, MAN2B1, NMI, QPCT, KCNJ2, JAML, MPZL3, NDC80, FRAT2, THEMIS2, CCL4, FCER1A, EVI2B, CD74, HLA-DRB5, TOR4A, GAPT, CXCR1, LAG3, CD68, NCKAP1L, TMEM33, and S100P as key crosstalk genes linking SLE and MMD. GO analysis indicated that these shared genes were predominantly enriched in immune system process and immune response. LASSO analysis identified MPZL3 as the optimal shared diagnostic biomarkers for both SLE and MMD. Additionally, the analysis of immune cell infiltration revealed the significant involvement of activation of T and monocytes cells in the pathogenesis of SLE and MMD.Conclusion: This study is pioneering in its use of bioinformatics tools to explore the close genetic relationship between MMD and SLE. The genes CAMP, CFD, MYO1F, CTSS, DEFA3, NLRP12, MAN2B1, NMI, QPCT, KCNJ2, JAML, MPZL3, NDC80, FRAT2, THEMIS2, CCL4, FCER1A, EVI2B, CD74, HLA-DRB5, TOR4A, GAPT, CXCR1, LAG3, CD68, NCKAP1L, TMEM33, and S100P have been identified as key crosstalk genes that connect MMD and SLE. Activation of T and monocytes cells-mediated immune responses are proposed to play a significant role in the association between MMD and SLE.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 37 references indexed in Scilit:
- Moyamoya disease emerging as an immune-related angiopathyTrends in Molecular Medicine, 2022
- Met–HER3 crosstalk supports proliferation via MPZL3 in MET-amplified cancer cellsCellular and Molecular Life Sciences, 2022
- Mitochondrially localized MPZL3 emerges as a signaling hub of mammalian physiologyBioEssays, 2021
- Association of increased Treg and Th17 with pathogenesis of moyamoya diseaseScientific Reports, 2017
- Network Analysis Identifies Mitochondrial Regulation of Epidermal Differentiation by MPZL3 and FDXRDevelopmental Cell, 2015
- Why have so few proteomic biomarkers “survived” validation? (Sample size and independent validation considerations)Proteomics, 2014
- Infections and autoimmunity – friends or foes?Trends in Immunology, 2009
- Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: Role of fat and carbohydrate mealsJACC, 2002
- Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (`Moyamoya' disease)Clinical Neurology and Neurosurgery, 1997
- Cerebrovascular "Moyamoya" DiseaseArchives of Neurology, 1969